Kintu K, Malaba T, Nakibuka J, et al. RCT of Dolutegravir vs Efavirenz-based therapy initiated in late pregnancy: DOLPHIN-2. CROI 2019, abstract 40-LB.
Effect van onderbreking methotrexaat op de immuniteit na de COVID-19-booster
jan 2023 | Psoriasis, RA, Vaccinatie, Virale infecties